Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 9, 2009, Pages 881-886

  Kovacs, Gabor ^a   Maier, Robert ^a   Aberer, Elisabeth ^a   Brodmann, Marianne ^a   Scheidl, Stefan ^a   Tröster, Natascha ^a   Hesse, Christian ^a   Salmhofer, Wolfgang ^a   Graninger, Winfried ^a   Gruenig, Ekkehard ^b   Rubin, Lewis J ^c   Olschewski, Horst ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Connective tissue disease; Exercise capacity; Pulmonary arterial hypertension; Pulmonary arterial pressure increase

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HEART INDEX; HUMAN; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; SYSTEMIC SCLEROSIS;

BLOOD PRESSURE; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; HEART CATHETERIZATION; HUMANS; MIDDLE AGED; REST; SCLERODERMA, SYSTEMIC; VASCULAR RESISTANCE; WALKING;

EID: 70350454775     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200904-0563OC     Document Type: Article

References (17)

1. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-2278. (Pubitemid 39610407)
2. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009;34:888-894.
3. Hamada K, Nagai S, Tanaka S, Handa T, Shigematsu M, Nagao T, Mishima M, Kitaichi M, Izumi T. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;131:650-656. (Pubitemid 46446853)
4. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:158-164. (Pubitemid 29036519)
5. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981;36:752-758. (Pubitemid 12249743)
6. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation 2008;118:2183-2189.
7. Oudiz RJ, Rubin LJ. Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular diseases. Circulation 2008;118:2120-2121.
8. Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD, Foley RJ, Silverman DI. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest 2006;130:176-181. (Pubitemid 44116857)
9. Collins N, Bastian B, Quiqueree L, Jones C, Morgan R, Reeves G. Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunitydatabase:PulmonaryHypertensionAssessment and Screening Evaluation using stress echocardiography (PHASE-I). Eur J Echocardiogr 2006;7:439-446. (Pubitemid 44645060)
10. Grunig E, Janssen B, Mereles D, Barth U, Borst MM, Vogt IR, Fischer C, Olschewski H, Kuecherer HF, Kubler W. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000;102:1145-1150. (Pubitemid 30672843)
11. Kovacs GR, Maier EA, Brodmann M, Scheidl S, Hesse C, Salmhofer W, Stauber R, Fürst F, Thonhofer R, Gruenig E, Olschewski H. Early recognition of pulmonary arterial hypertension in patients with connective tissue disease using exercise stress-echocardiography, cardiopulmonary exercise test and right heart catheterisation. Eur Resp J 2007:30:1803.
12. Pignone A, Mori F, Pieri F, Oddo A, Galeota G, Fiori G, Del Rosso A, Perfetto F, Becucci A, Livi R, et al. Exercise doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 2007;1108:291-304. (Pubitemid 47528742)
13. Callejas-Rubio JL, Moreno-Escobar E, de la Fuente PM, Perez LL, Fernandez RR, Sanchez-Cano D, Mora JP, Ortego-Centeno N. Prevalence of exercise pulmonary arterial hypertension in scleroderma. J Rheumatol 2008;35:1812-1816.
14. Steen V, Chou M, Shanmugam V, Mathias M, Kuru T, Morrissey R. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008;134:146-151. (Pubitemid 352008776)
15. Wensel R, Opitz CF, Anker SD, Winkler J, Hoffken G, Kleber FX, Sharma R, Hummel M, Hetzer R, Ewert R. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106: 319-324. (Pubitemid 34778955)
16. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, Miyatake K. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-492. (Pubitemid 30129457)
17. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.